Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
125.00    -0.50 (-0.40%)
Bid:
125.00
Ask:
129.50
Spread: 4.50 (3.60%)
Market Cap: £199.15m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director Dealing, New Equity, Total Voting Rights

24 Jun 2016 14:55

RNS Number : 2529C
Redcentric PLC
24 June 2016
Β 

24 June 2016

Redcentric plc

("Redcentric", "the Company" or "the Group")

Β 

Director's Dealings, Issue of Equity and Total Voting Rights

Β 

Redcentric plc (AIM: RCN), announces that it has received notification from Fraser Fisher, Chief Executive Officer, that he exercised 200,000 options over ordinary shares of 0.1p each in the Company ("Shares") on 23 June 2016, at an exercise price of 70 pence per Share, pursuant to the Company's EMI Plan 2013. Following this exercise, Mr Fisher sold 200,000 Shares at an average price of 180 pence per Share on 23 June 2016. In addition, the Company announces that on 23 June 2016 it received notices of exercise in relation to the exercise of employee share options over 237,500 Shares issued under the Company's Unapproved Share Option Plan.

Accordingly, application has been made for the 437,500 Shares issued pursuant to the option exercise to be admitted to trading on AIM. The new Shares will rank pari passu with the Company's existing Shares and it is expected that admission will become effective and dealings in the new Shares will commence at 8.00 a.m. on 30 June 2016.

Both before and after the exercise and sale, Mr Fisher held 90,557 Shares, representing a beneficial interest in the Company of 0.06% of the current issued share capital. In addition, Mr Fisher holds options over 1,159,933 Shares; 561,143 of which have vested, 581,968 of which are subject to performance conditions, and 16,822 of which are part of the Redcentric SAYE Option Plan 2014.

Following the issue of the 437,500 Shares, the Company will have a total of 146,318,685 Ordinary Shares in issue with one voting right per share.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

Β 

Enquiries:

Β 

Redcentric plc

+44 (0)1423 850 000

Fraser Fisher, Chief Executive Officer

Β 

Tim Coleman, Chief Financial Officer

Β 

Β 

Β 

Numis Securities Limited - Nomad & Joint Broker

+44 (0)20 7260 1000

Simon Willis / Oliver Hardy / Ben Stoop

Β 

Β 

Β 

finnCap Ltd - Joint Broker

+44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

Β 

Β 

Β 

MXC Capital Markets LLP - Financial Adviser

+44 (0)20 7965 8149

Marc Young / Charlotte Stranner

Β 

Β 

Β 

Tulchan

+44 (0)20 7353 4200

James Macey White / Matt Low

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCSEFFDLFMSEIM
Date   Source Headline
19th Jun 20267:00 amRNSProposed £90 million Tender Offer & Notice of GM
1st Jun 20267:01 amRNSAppointment of Chief Financial Officer
1st Jun 20267:00 amRNSTrading Update
13th May 20261:25 pmRNSCapital Reduction Result of General Meeting
12th May 20267:00 amRNSExercise of Options
1st May 20267:00 amRNSCompletion of Sale of Redcentric Data Centres Ltd
24th Apr 20267:00 amRNSProposed Capital Reduction & Notice of GM
14th Apr 20267:00 amRNSExercise of Options
8th Apr 202612:55 pmRNSDirector/PDMR Shareholdings
19th Mar 20263:26 pmRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
13th Mar 20267:00 amRNSExercise of Options
23rd Feb 20261:00 pmRNSHolding(s) in Company
20th Feb 20267:00 amRNSExercise of Options
9th Jan 202610:09 amRNSExercise of Options
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 202512:15 pmRNSDirector/PDMR Share Dealing
31st Dec 20257:00 amRNSExercise of Options
31st Dec 20257:00 amRNSExercise of Options
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:01 amRNSDirector/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
29th Dec 20257:00 amRNSReplacement: Director/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
24th Dec 20259:55 amRNSDirector/PDMR Share Dealing
22nd Dec 202511:46 amRNSGrant of Options
22nd Dec 202511:46 amRNSGrant of Options
12th Dec 20253:49 pmRNSDirector/PDMR Shareholdings
11th Dec 20257:00 amRNSExercise of Options
10th Dec 20257:00 amRNSHalf Year Results
4th Dec 20257:00 amRNS-RPresentation via Investor Meet Company
14th Nov 20257:00 amRNSExercise of Options
6th Nov 20258:00 amRNSSAYE Share Option Scheme
5th Nov 20257:00 amRNSH1 Trading Update and Notice of Results
27th Oct 20254:36 pmRNSHolding(s) in Company
24th Oct 20257:00 amRNSExercise of Options
23rd Oct 20257:00 amRNSDisposal of Redcentric Data Centres Limited
20th Oct 20254:48 pmRNSResult of AGM
17th Oct 202512:40 pmRNSExercise of Options
13th Oct 20259:40 amRNSExercise of Options
3rd Oct 20257:00 amRNSExercise of Options
25th Sep 20257:00 amRNSPublication of Annual Report and Notice of AGM
24th Sep 20257:00 amRNSFinal Results
2nd Sep 20257:00 amRNSNotice of Final Results
22nd Aug 20251:13 pmRNSResponse to recent press speculation
19th Aug 20257:00 amRNSAppointment of Chief Financial Officer
1st Aug 20257:00 amRNSExercise of Options
7th Jul 20257:00 amRNSExercise of Options
23rd Jun 20257:00 amRNSExercise of Options
17th Jun 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.